New RSV Vaccine Program Launching September 2024
Starting in September 2024, the NHS will introduce a new vaccine program to protect against Respiratory Syncytial Virus (RSV) for older adults. This vaccine will be available to individuals from their 75th birthday until they turn 80. Routine vaccinations will be offered when you turn 75, but there will be a special catch-up campaign this autumn for those aged 75 to 78.
Key Details:
- Routine Vaccination: Starting from your 75th birthday.
- Catch-Up Campaign: For those aged 75 to 78 during autumn 2024.
- Special Eligibility: Patients who are 79 years old on 31st August 2024 will be eligible for the vaccine until 31st August 2025. This group will be the only exception to the age limit of 80.
About RSV: RSV is a respiratory virus that affects the airways and lungs. It often presents symptoms similar to a cold, such as a cough, sore throat, sneezing, and a runny or blocked nose. In severe cases, it can cause wheezing, shortness of breath, pneumonia, and other life-threatening conditions. While most infections resolve on their own, RSV can be particularly dangerous for older adults and those with underlying health conditions like heart or lung disease or a weakened immune system.
RSV in Children and Pregnant Women: RSV is common in young children but can be severe for infants and older adults. Therefore, the vaccine will also be offered to pregnant women starting from 28 weeks gestation. This offer will be coordinated by your midwife, not the practice.
Additional Vaccinations: This new RSV vaccine is in addition to your annual seasonal influenza vaccine, which will be offered by the practice as usual. Additionally, your COVID-19 autumn booster will be available at local pharmacies. We encourage you to take advantage of all three vaccines to ensure comprehensive protection as we head into the colder months.
This new vaccine program aims to protect those most vulnerable to RSV, ensuring better health outcomes for our community.